orthostatic hypotension tirzepatide with nondipping: phenotype of neurodegenerative disease Call to action for drug

Do not use in individuals with known hypersensitivity to benzyl alcohol

Bertelsen, J

By using Melanoboost before heading outdoors, you can optimise your tanning potential outdoors

Abstract Aims/hypothesis We aimed to determine whether the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) in individuals with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus decreases the risk of new-onset adverse cardiovascular events (CVEs) and mortality rate compared with other glucose-lowering drugs in a real setting at a population level

The frustration experienced by these patients often stems from unrealistic expectations and inadequate medical supervision

This review systematically explores the mechanistic links between gut microbiota and hypothyroidism, critically evaluates current microbiota-based therapeutic strategies, and highlights future opportunities for personalized, microbiome-driven interventions to optimize the management of hypothyroidism